Skip to main content
Log in

Cyclin D1 G870A polymorphism and colorectal cancer susceptibility: a meta-analysis of 20 populations

  • Original Article
  • Published:
International Journal of Colorectal Disease Aims and scope Submit manuscript

Abstract

Purpose

Studies investigating the association between genetic polymorphism of cyclin D1 (CCND1) G870A and risk of colorectal cancer (CRC) reported conflicting results. In order to derive a more precise estimation of the relationship, a meta-analysis was performed.

Materials and methods

We performed an extensive search of relevant studies and carried out a meta-analysis, including 20 studies with 5,975 cases and 8,333 controls, to obtain a more precise estimate.

Results

Overall, significantly elevated colorectal cancer risk was associated with variant allele 870A when all studies were pooled (AA vs. GG: OR = 1.23, 95% CI = 1.04–1.44; GA vs. GG: OR = 1.13, 95% CI = 1.01–1.26; dominant model: OR = 1.16, 95% CI = 1.03–1.31). In the subgroup analysis by ethnicity, significantly increased risks were detected among Caucasians (AA vs. GG: OR = 1.27, 95% CI = 1.04–1.44; dominant model: OR = 1.17, 95% CI = 1.02–1.34).We also observed sporadic CRC with an increased cancer susceptibility (AA vs. GG: OR = 1.24, 95% CI = 1.04–1.48; dominant model: OR = 1.17, 95% CI = 1.04–1.33), when colorectal cancer was stratified into sporadic CRC and hereditary nonpolyposis colorectal cancer (HNPCC). However, no significant associations were found in both Asians and HNPCC patients for all genetic models.

Conclusion

Result suggests that the cyclin D1 870A allele is a low-penetrant risk factor for developing sporadic colorectal cancer, especially among Caucasians.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics, 2010. CA Cancer J Clin 60(5):277–300

    Article  PubMed  Google Scholar 

  2. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, Pukkala E, Skytthe A, Hemminki K (2000) Environmental and heritable factors in the causation of cancer—analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 343(2):78–85

    Article  PubMed  CAS  Google Scholar 

  3. Hall M, Peters G (1996) Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer. Adv Cancer Res 68:67–108

    Article  PubMed  CAS  Google Scholar 

  4. Solomon DA, Wang Y, Fox SR, Lambeck TC, Giesting S, Lan Z, Senderowicz AM, Conti CJ, Knudsen ES (2003) Cyclin D1 splice variants. Differential effects on localization, RB phosphorylation, and cellular transformation. J Biol Chem 278(32):30339–30347

    Article  PubMed  CAS  Google Scholar 

  5. Bala S, Peltomaki P (2001) CYCLIN D1 as a genetic modifier in hereditary nonpolyposis colorectal cancer. Cancer Res 61(16):6042–6045

    PubMed  CAS  Google Scholar 

  6. Forones NM, de Lima JM, de Souza LG, da Silva ID (2008) Cyclin D1 A870G polymorphism in Brazilian colorectal cancer patients. J Gastrointest Cancer 39(1–4):118–123

    Article  PubMed  CAS  Google Scholar 

  7. Grieu F, Malaney S, Ward R, Joseph D, Iacopetta B (2003) Lack of association between CCND1 G870A polymorphism and the risk of breast and colorectal cancers. Anticancer Res 23(5b):4257–4259

    PubMed  CAS  Google Scholar 

  8. Grunhage F, Jungck M, Lamberti C, Berg C, Becker U, Schulte-Witte H, Plassmann D, Rahner N, Aretz S, Friedrichs N, Buettner R, Sauerbruch T, Lammert F (2008) Association of familial colorectal cancer with variants in the E-cadherin (CDH1) and cyclin D1 (CCND1) genes. Int J Colorectal Dis 23(2):147–154

    Article  PubMed  Google Scholar 

  9. Hong Y, Eu KW, Seow-Choen F, Fook-Chong S, Cheah PY (2005) GG genotype of cyclin D1 G870A polymorphism is associated with increased risk and advanced colorectal cancer in patients in Singapore. Eur J Cancer 41(7):1037–1044

    Article  PubMed  CAS  Google Scholar 

  10. Huang WS, Tang R, Lin PY, Changchien CR, Chen JS, Chiang JM, Yeh CY, Wang JY, Hsieh LL (2006) Impact of the cyclin D1 A870G polymorphism on susceptibility to sporadic colorectal cancer in Taiwan. Dis Colon Rectum 49(5):602–608

    Article  PubMed  Google Scholar 

  11. Jiang J, Wang J, Suzuki S, Gajalakshmi V, Kuriki K, Zhao Y, Nakamura S, Akasaka S, Ishikawa H, Tokudome S (2006) Elevated risk of colorectal cancer associated with the AA genotype of the cyclin D1 A870G polymorphism in an Indian population. J Cancer Res Clin Oncol 132(3):193–199

    Article  PubMed  CAS  Google Scholar 

  12. Jing J, Xiong W, Jin H, Ji B (2008) Relationship between CCND1 gene A870G polymorphism and genetic susceptibility to colorectal cancer. World Chinese Journal of Digestology 16(22):2553–2556

    CAS  Google Scholar 

  13. Kong S, Amos CI, Luthra R, Lynch PM, Levin B, Frazier ML (2000) Effects of cyclin D1 polymorphism on age of onset of hereditary nonpolyposis colorectal cancer. Cancer Res 60(2):249–252

    PubMed  CAS  Google Scholar 

  14. Kong S, Wei Q, Amos CI, Lynch PM, Levin B, Zong J, Frazier ML (2001) Cyclin D1 polymorphism and increased risk of colorectal cancer at young age. J Natl Cancer Inst 93(14):1106–1108

    Article  PubMed  CAS  Google Scholar 

  15. Kruger S, Engel C, Bier A, Mangold E, Pagenstecher C, Doeberitz MK, Holinski-Feder E, Moeslein G, Keller G, Kunstmann E, Friedl W, Plaschke J, Ruschoff J, Schackert HK (2006) Absence of association between cyclin D1 (CCND1) G870A polymorphism and age of onset in hereditary nonpolyposis colorectal cancer. Cancer Lett 236(2):191–197

    Article  PubMed  Google Scholar 

  16. Le Marchand L, Seifried A, Lum-Jones A, Donlon T, Wilkens LR (2003) Association of the cyclin D1 A870G polymorphism with advanced colorectal cancer. JAMA 290(21):2843–2848

    Article  PubMed  Google Scholar 

  17. Liu B, Zhang Y, Jin M, Ni Q, Liang X, Ma X, Yao K, Li Q, Chen K (2010) Association of selected polymorphisms of CCND1, p21, and caspase8 with colorectal cancer risk. Mol Carcinog 49(1):75–84

    Article  PubMed  CAS  Google Scholar 

  18. McKay JA, Douglas JJ, Ross VG, Curran S, Murray GI, Cassidy J, McLeod HL (2000) Cyclin D1 protein expression and gene polymorphism in colorectal cancer. Aberdeen Colorectal Initiative. Int J Cancer 88(1):77–81

    Article  PubMed  CAS  Google Scholar 

  19. Porter TR, Richards FM, Houlston RS, Evans DG, Jankowski JA, Macdonald F, Norbury G, Payne SJ, Fisher SA, Tomlinson I, Maher ER (2002) Contribution of cyclin d1 (CCND1) and E-cadherin (CDH1) polymorphisms to familial and sporadic colorectal cancer. Oncogene 21(12):1928–1933

    Article  PubMed  CAS  Google Scholar 

  20. Probst-Hensch NM, Sun CL, Van Den Berg D, Ceschi M, Koh WP, Yu MC (2006) The effect of the cyclin D1 (CCND1) A870G polymorphism on colorectal cancer risk is modified by glutathione-S-transferase polymorphisms and isothiocyanate intake in the Singapore Chinese Health Study. Carcinogenesis 27(12):2475–2482

    Article  PubMed  CAS  Google Scholar 

  21. Schernhammer ES, Tranah GJ, Giovannucci E, Chan AT, Ma J, Colditz GA, Hunter DJ, Willett WC, Fuchs CS (2006) Cyclin D1 A870G polymorphism and the risk of colorectal cancer and adenoma. Br J Cancer 94(6):928–934

    Article  PubMed  CAS  Google Scholar 

  22. Talseth BA, Ashton KA, Meldrum C, Suchy J, Kurzawski G, Lubinski J, Scott RJ (2008) Aurora-A and Cyclin D1 polymorphisms and the age of onset of colorectal cancer in hereditary nonpolyposis colorectal cancer. Int J Cancer 122(6):1273–1277

    Article  PubMed  CAS  Google Scholar 

  23. Tan XL, Nieters A, Kropp S, Hoffmeister M, Brenner H, Chang-Claude J (2008) The association of cyclin D1 G870A and E-cadherin C-160A polymorphisms with the risk of colorectal cancer in a case control study and meta-analysis. Int J Cancer 122(11):2573–2580

    Article  PubMed  CAS  Google Scholar 

  24. Yaylim-Eraltan I, Arikan S, Yildiz Y, Cacina C, Ergen HA, Tuna G, Gormus U, Zeybek U, Isbir T (2010) The influence of cyclin D1 A870G polymorphism on colorectal cancer risk and prognosis in a Turkish population. Anticancer Res 30(7):2875–2880

    PubMed  CAS  Google Scholar 

  25. Guo SW, Thompson EA (1992) Performing the exact test of Hardy–Weinberg proportion for multiple alleles. Biometrics 48(2):361–372

    Article  PubMed  CAS  Google Scholar 

  26. Cochran W (1954) The combination of estimates from different experiments. Biometrics 10:101–129

    Article  Google Scholar 

  27. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22(4):719–748

    PubMed  CAS  Google Scholar 

  28. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177–188

    Article  PubMed  CAS  Google Scholar 

  29. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629–634

    PubMed  CAS  Google Scholar 

  30. Tejpar S, Van Cutsem E (2002) Molecular and genetic defects in colorectal tumorigenesis. Best Pract Res Clin Gastroenterol 16(2):171–185

    Article  PubMed  CAS  Google Scholar 

  31. Donnellan R, Chetty R (1998) Cyclin D1 and human neoplasia. Mol Pathol 51(1):1–7

    Article  PubMed  CAS  Google Scholar 

  32. Palmqvist R, Stenling R, Oberg A, Landberg G (1998) Expression of cyclin D1 and retinoblastoma protein in colorectal cancer. Eur J Cancer 34(10):1575–1581

    Article  PubMed  CAS  Google Scholar 

  33. Pabalan N, Bapat B, Sung L, Jarjanazi H, Francisco-Pabalan O, Ozcelik H (2008) Cyclin D1 Pro241Pro (CCND1-G870A) polymorphism is associated with increased cancer risk in human populations: a meta-analysis. Canc Epidemiol Biomarkers Prev 17(10):2773–81

    Article  CAS  Google Scholar 

  34. Hirschhorn JN, Lohmueller K, Byrne E, Hirschhorn K (2002) A comprehensive review of genetic association studies. Genet Med 4(2):45–61

    Article  PubMed  CAS  Google Scholar 

  35. Wacholder S, Chanock S, Garcia-Closas M, El Ghormli L, Rothman N (2004) Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst 96(6):434–442

    Article  PubMed  Google Scholar 

  36. Liu B, Parsons R, Papadopoulos N, Nicolaides NC, Lynch HT, Watson P, Jass JR, Dunlop M, Wyllie A, Peltomaki P, de la Chapelle A, Hamilton SR, Vogelstein B, Kinzler KW (1996) Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nat Med 2(2):169–174

    Article  PubMed  CAS  Google Scholar 

  37. Munafo MR, Flint J (2004) Meta-analysis of genetic association studies. Trends Genet 20(9):439–444

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest statement

None declared.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jian-Nong Zhou.

Additional information

Lou-Qian Zhang and Jun Wang contributed equally to this work and should be considered as co-first authors.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhang, LQ., Wang, J., Shang, JQ. et al. Cyclin D1 G870A polymorphism and colorectal cancer susceptibility: a meta-analysis of 20 populations. Int J Colorectal Dis 26, 1249–1255 (2011). https://doi.org/10.1007/s00384-011-1220-x

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00384-011-1220-x

Keywords

Navigation